Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tijan Ventures appears to have been a boutique life sciences advisory business rather than a therapeutic product company. Public references describe it as providing strategic advisory, capital raising, interim executive management, and executive/non-executive leadership services to life sciences companies, with particular focus areas including biologics, cell and gene therapies, immunotherapy, and regenerative medicine. Multiple later biographies of its former executive leader, Tim Oldham, refer to Tijan Ventures in the past tense as a prior role, and no current standalone operating presence or active corporate website is readily identifiable. Based on the available evidence, it is best characterized as a now-inactive life sciences advisory firm, likely based in Australia, rather than an active biotech developer with a clinical pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tijan Ventures.